New Guidelines on PSMA PET CT for High Risk Prostate Cancer

APCCC 2024 Day 1 Session 1Подробнее

2024 EAU Prostate Cancer Guidelines - some big changes!!Подробнее

Imaging for High-Risk Prostate Cancer: The Guidelines and BeyondПодробнее

UROwebinar: Can PSMA PET/CT spare extended pelvic lymph node dissection in high-risk prostate cancerПодробнее

Next Generation Imaging (PSMA) and Introduction to TheranosticsПодробнее

How to use PSMA-PET/CT in the Management of Relapsing Prostate Cancer Patients Webcast (2023)Подробнее

New AUA Guideline (2024): Salvage Therapy for Prostate Cancer (2024)Подробнее

Three big questions in high-risk prostate cancer | With Boris and TylerПодробнее

How to use Prostate-Specific Membrane Antigen-Positron Emission Tomography/CT (2024)Подробнее

Imaging, PSMA PET/CT cases (pre/post therapy)Подробнее

Optimal treatment of clinically node-positive prostate cancer in the PSMA PET/CT eraПодробнее

Optimizing Management of High-risk Prostate Cancer PatientsПодробнее

Theranostics in Prostate Cancer: New Therapies for the 21st and 22nd CenturiesПодробнее

Guidelines for using PSMA PET in the staging of prostate cancerПодробнее

Appropriate Use of PSMA PET in Clinical PracticeПодробнее

The OncoAlert Tumor Boards Prostate Cancer June 20, 2022Подробнее

Prostate Cancer Masterclass - 12 Sep 2020Подробнее

What is the BEST Way to See if Prostate Cancer Has Spread?Подробнее

NCCN Guidelines for Treatment of Localized Prostate CancerПодробнее